People | June 11, 2022
AIkido Pharma appoints Soo Yu as Director
New Director supports NASDAQ rule on diversity
New Director supports NASDAQ rule on diversity
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Subscribe To Our Newsletter & Stay Updated
